Comparison Overview
J&J Innovative Medicine Belgium
J&J Innovative Medicine Belgium
Turnhoutseweg 30, Beerse, 2340, BE
Last Update: 25/02/2026
At Johnson & Johnson Innovative Medicine, we are leading where medicine is going. The experiences of patients around the world inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science with compassion, we confid...
Catalent
101 E Kennedy Blvd, Tampa, Florida, US, 33602
Last Update: 04/04/2026
Championing the missions that matter™. Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) and trusted partner to pharma, biotech, and consumer health companies worldwide. We put patients first in everything we do, helping peopl...
Compliance Ranges Comparison
J&J Innovative Medicine Belgium
Catalent
Benchmark & Cyber Underwriting Signals
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for J&J Innovative Medicine Belgium in 2026.
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Catalent in 2026.
Incident History - J&J Innovative Medicine Belgium (X = Date, Y = Severity)
J&J Innovative Medicine Belgium cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Catalent (X = Date, Y = Severity)
Catalent cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents
J&J Innovative Medicine Belgium
Catalent
FAQ
Latest Global CVEs
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an inadequate encryption strength vulnerability which could allow an attacker to steal admin credentials via weak hash or a pass-the-hash attack.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could allow for asset discovery by unauthenticated users.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an unintended proxy or intermediary vulnerability which could allow an attacker to use an active proxy, which would bypass OT segmentation.
Pronetiqs IntraVUE Versions 3.2.1a14 and prior have a plaintext storage of a password vulnerability that could expose cleartext credentials through the API.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could expose the underlying host/share filesystem.